Mode
Text Size
Log in / Sign up
N/A Completed N=276 Randomized Single-blind Treatment

Performance of Two Silicone Hydrogel Toric Contact Lenses

Vision Correction
Source: ClinicalTrials.gov NCT00638846 ↗
Enrolled (actual)
276
Serious AEs
0.0%
Results posted
Jul 2010
Primary outcomePrimary: Lens Orientation — 0.77; 0.66 proportion of eyes

Summary

Evaluation of the clinical performance of two toric contact lenses in a 2-week, single masked (subject), daily wear, randomized, bilateral, parallel group study.

Outcome Measures

OutcomeResultp-value
PRIMARY
Lens Orientation
0.77; 0.66 —
PRIMARY
Lens Stability
0.89; 0.88 —
PRIMARY
Subjective Comfort
0.1942; -0.1738 —
SECONDARY
Time to Fit Lens
6.2789; 7.4095 —
SECONDARY
Subjective Lens Vision
0.1942; -0.1738 —
SECONDARY
Overall Corneal Staining
0.0919; 0.1607 —

Eligibility Criteria

Inclusion Criteria

  • Be between 18 and 45 years of age.
  • Sign Written Informed Consent (See separate document).
  • Be an existing successful daily wear toric soft contact lens.
  • Require a visual correction in both eyes (monovision or uniocular fitting is NOT allowed).
  • Does not require presbyopic correction (can read J1 @ normal reading distance).
  • Have a sphere requirement in the range -1.00 and -5.00D (-5.25D refractive)
  • Have refractive astigmatism between 0.75D and 2.50D in both eyes.
  • Achieve visual acuity of 20/30 or better in each eye with spherical distance correction.
  • Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having:
  • No amblyopia.
  • No evidence of lid abnormality or infection.
  • No conjunctival abnormality or infection.
  • No clinically significant slit lamp findings (i.e. stromal edema, vascularisation, infiltrates or abnormal opacities).
  • No other active ocular disease.

Exclusion Criteria

  • Requires concurrent ocular medication.
  • Clinically significant (Grade 3 or 4) corneal stromal haze, corneal vascularisation, tarsal abnormalities, bulbar hyperemia, limbal hyperemia, or any other abnormality of the cornea that would contraindicate contact lens wear.
  • Corneal staining Grade 3 in more than one region.
  • Has had refractive surgery. Has had eye injury/surgery within 8 weeks immediately prior to enrolment for this study.
  • Abnormal lacrimal secretions.
  • Pre-existing ocular irritation that would preclude contact lens fitting.
  • Keratoconus or other corneal irregularity.
  • Polymethyl methacrylate (PMMA) or Rigid Gas Permeable (RGP) lens wear in the previous 8 weeks
  • Extended lens wear in last 3 months.
  • Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
  • Diabetic.
  • Infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV).
  • Pregnancy, lactating or planning a pregnancy at the time of enrolment.
  • Participation in any concurrent clinical trial or in last 60 days.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00638846). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search